STONY BROOK, N.Y., July 25 /PRNewswire-FirstCall/ -- Applied DNA
Sciences, Inc. (OTC Bulletin Board: APDN), a DNA security solutions
company, announced today the completion of its first contract with Dr.
Suwelack Skin & Healthcare AG ("Suwelack"). Suwelack is recognized in
Germany as the leader in the innovation, development and manufacture of
biomatrices for cosmeceutical and healthcare applications.
On May 9, 2006, Suwelack adopted APDN's SigNature(TM) Program as one of
many new initiatives that complement its expansion into the North American
market. APDN's SigNature(TM) logo was printed with ink containing APDN's
encrypted botanical DNA technology, onto Suwelack's annual supply of
packaging and labels.
Dr. James A. Hayward, CEO of APDN, stated: "We believe that the
completion of our first contract to supply DNA embedded packaging and
labels for Suwelack is a strong indication that our DNA technology is
ready-to-implement. The Suwelack project took less than 3 months from start
to finish, including negotiations, design, technical specification, DNA
embedment, printing and authentication validations."
APDN's forensic-based technology can also help to enhance the power of
existing security technologies such as barcoding, RFIDs, smart cards, and
optical memory-based ID systems without adding significant cost or change
to operations and finished goods.
APDN also today announced that Dr. Stephane Shu Kin So has joined the
scientific team at the APDN laboratories in Stony Brook. Dr. Shu Kin So
received his Ph.D. in Molecular Genetics and Microbiology from State
University of New York in Stony Brook and has considerable experience in
molecular biology techniques, DNA cloning and genetic manipulations in
bacteria. He also received his Bachelor of Science Degree in Biology from
Binghamton University in Binghamton, New York.
Dr. Benjamin Liang, Strategic Technology Development Officer, stated:
"The addition of Dr. Shu Kin So is critical to our authentication
operations which are now fully functional. Our team provides services to
governments and corporations, and continues to refine and shorten forensic
About Applied DNA Sciences, Inc.
Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded
security solutions that use plant DNA to verify authenticity and protect
corporate and government agencies from counterfeiting, fraud, piracy,
product diversion, identity theft and unauthorized intrusion into physical
plant and databases. Our common stock is registered under Section 12(g) of
the Securities Exchange Act of 1934 and is listed on the Over-The-Counter
Bulletin Board under the symbol "APDN". Contact: MeiLin Wan, Applied DNA
Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel:
631-444- 6370; Fax: 631-444.8848 http://www.ADNAS.com.
About Dr. Suwelack Skin & Healthcare AG
Dr. Suwelack Skin & Healthcare AG manufactures biomatrices for skin and
healthcare for cosmeceutical and medical applications. Suwelack's patented
technology uses a freeze-drying process to gently extract water from
natural raw materials, as a result of which the raw materials are preserved
in a highly pure form. By using this technique the company is able to avoid
using preservative agents, chemical cross-linking agents and perfumes and
ensure the basis for skin compatibility. Contact: Nikolaus Uleer, Dr.
Suwelack Skin & Healthcare AG, Josef-Suwelack-Strasse, 48727 Billerbeck,
Germany Tel: +49-2543-72-247 Fax: +49-2543-72-365
The statements made by Applied DNA Sciences, Inc. may be
forward-looking in nature and are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements describe the Company's future plans,
projections, strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are beyond the
control of Applied DNA Sciences, Inc. Actual results could differ
materially from those projected due to changes in interest rates, market
competition, changes in the local and national economies, and various other
factors detailed from time to time in Applied DNA Sciences' SEC reports and
filings, including our Form 10-KSB, filed on January 12, 2006, our
subsequent Quarterly Reports on Form 10-QSB, and our Current Reports on
Form 8-K . The Company undertakes no obligation to update publicly any
forward- looking statements to reflect new information, events or
circumstances after the date hereof to reflect the occurrence of
SOURCE Applied DNA Sciences, Inc.